| 41 |
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 42 |
Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazolinebased derivatives as dual EGFR and HER-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 43 |
Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 44 |
Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole/3-cyanopyridin-2-one hybrids as dual EGFR/BRAFV600E inhibitors |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 45 |
Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 46 |
Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors |
قسم الكيمياء الدوائية |
2025 |
| 47 |
Design, synthesis, molecular modeling, and antiproliferative evaluation of new 2-oxoindolin-3-ylidene thiazole derivatives |
قسم الكيمياء الدوائية |
2025 |
| 48 |
Discovery of a novel 1H-pyrazole -[3,4-d] pyrimidine inhibitor based on phenotypic screening for esophageal cancer: Weak cardiotoxicity |
قسم الكيمياء العضوية الصيدلية |
2025 |
| 49 |
Disposable and sensitive electrochemical magneto-immunosensor for point-of-care HCV diagnostics: Targeting HCVcAg, the active viremia biomarker, in patient samples |
قسم الكيمياء التحليلية الصيدلية |
2025 |
| 50 |
Dual-emission ratiometric fluorometric platform using Cu@NCDs/eosin system for sensitive detection of metformin: Pharmacokinetic studies in normal and disease states |
قسم الكيمياء التحليلية الصيدلية |
2025 |
